Picture of Sinopharm logo

1099 — Sinopharm News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareBalancedLarge CapContrarian

Brief: Sinopharm Reports Qtrly Profit Attributable RMB1.43 Billion

April 22 (Reuters) - Sinopharm Group Co Ltd  1099.HK :
    * QTRLY PROFIT ATTRIBUTABLE RMB1.43 BILLION VERSUS RMB1.22
BILLION
    * QTRLY TOTAL OPERATING REVENUE RMB127.60 BILLION VERSUS
RMB120.27
BILLION

Source text for Eikon:  ID:nHKS1gFrQC 
Further company coverage:  1099.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Sinopharm

See all news